These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6354022)

  • 1. Mediator release after nasal airway challenge with allergen.
    Naclerio RM; Meier HL; Kagey-Sobotka A; Adkinson NF; Meyers DA; Norman PS; Lichtenstein LM
    Am Rev Respir Dis; 1983 Oct; 128(4):597-602. PubMed ID: 6354022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.
    Creticos PS; Adkinson NF; Kagey-Sobotka A; Proud D; Meier HL; Naclerio RM; Lichtenstein LM; Norman PS
    J Clin Invest; 1985 Dec; 76(6):2247-53. PubMed ID: 2416777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.
    Pipkorn U; Proud D; Lichtenstein LM; Schleimer RP; Peters SP; Adkinson NF; Kagey-Sobotka A; Norman PS; Naclerio RM
    J Clin Invest; 1987 Oct; 80(4):957-61. PubMed ID: 2443539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo demonstration of inflammatory mediator release following nasal challenge with antigen.
    Naclerio RM; Meier HL; Adkinson NF; Kagey-Sobotka A; Meyers DA; Norman PS; Lichtenstein LM
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():26-32. PubMed ID: 6578074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediator release after allergic and physical nasal challenges.
    Norman PS; Naclerio RM; Creticos PS; Togias A; Lichtenstein LM
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):57-63. PubMed ID: 2409027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory mediators in late antigen-induced rhinitis.
    Naclerio RM; Proud D; Togias AG; Adkinson NF; Meyers DA; Kagey-Sobotka A; Plaut M; Norman PS; Lichtenstein LM
    N Engl J Med; 1985 Jul; 313(2):65-70. PubMed ID: 2582257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
    Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptase in nasal lavage fluid after local allergen challenge. Relationship to histamine levels and TAME-esterase activity.
    Juliusson S; Holmberg K; Baumgarten CR; Olsson M; Enander I; Pipkorn U
    Allergy; 1991 Aug; 46(6):459-65. PubMed ID: 1957995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions.
    Raphael GD; Igarashi Y; White MV; Kaliner MA
    J Allergy Clin Immunol; 1991 Jul; 88(1):33-42. PubMed ID: 1712803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin attenuates symptoms and mast cell degranulation induced by AMP nasal provocation.
    Zeng D; Prosperini G; Russo C; Spicuzza L; Cacciola RR; Di Maria GU; Polosa R
    J Allergy Clin Immunol; 2004 Aug; 114(2):316-20. PubMed ID: 15316509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-provoked increase in histamine reactivity. Observations on mechanisms.
    Walden SM; Proud D; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):642-8. PubMed ID: 1892305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement.
    Togias AG; Naclerio RM; Proud D; Fish JE; Adkinson NF; Kagey-Sobotka A; Norman PS; Lichtenstein LM
    J Clin Invest; 1985 Oct; 76(4):1375-81. PubMed ID: 2414318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P enhances antigen-evoked mediator release from human nasal mucosa.
    Baumgarten CR; Witzel A; Kleine-Tebbe J; Kunkel G
    Peptides; 1996; 17(1):25-30. PubMed ID: 8822506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mediators of immunologic inflammation of the respiratory tract].
    Miadonna A; Tedeschi A
    Boll Ist Sieroter Milan; 1988; 67(5-6):369-76. PubMed ID: 3155333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachidonic acid metabolites during nasal challenge.
    Brown MS; Peters SP; Adkinson NF; Proud D; Kagey-Sobotka A; Norman PS; Lichtenstein LM; Naclerio RM
    Arch Otolaryngol Head Neck Surg; 1987 Feb; 113(2):179-83. PubMed ID: 3099812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline reduces the response to nasal challenge with antigen.
    Naclerio RM; Bartenfelder D; Proud D; Togias AG; Meyers DA; Kagey-Sobotka A; Norman PS; Lichtenstein LM
    Am J Med; 1985 Dec; 79(6A):43-7. PubMed ID: 2417477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does laser turbinectomy influence local allergic inflammation in the nose?
    Jovanovic S; Dokic D
    Rhinology; 1996 Mar; 34(1):46-9. PubMed ID: 8739871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen.
    Proud D; Sweet J; Stein P; Settipane RA; Kagey-Sobotka A; Friedlaender MH; Lichtenstein LM
    J Allergy Clin Immunol; 1990 May; 85(5):896-905. PubMed ID: 1692049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis.
    Guyer BJ; Shimamoto SR; Bradhurst AL; Grossbard EB; Dreskin SC; Nelson HS
    Allergy Asthma Proc; 2006; 27(3):208-13. PubMed ID: 16913263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergen-induced nasal hyperreactivity appears unrelated to the size of the nasal and dermal immediate allergic reaction.
    Andersson M; von Kogerer B; Andersson P; Pipkorn U
    Allergy; 1987 Nov; 42(8):631-7. PubMed ID: 3322084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.